Atlas Trials

Clostridium Difficile Infection Recurrence

15 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Clostridium Difficile Infection Recurrence

RecordFirmDate
A Study of ART24 in Subjects Recently Cured of a Clostridioides Difficile Infection (CDI) (NCT04891965)Adiso Therapeutics2020-02-27
Real-world Evaluation of Bezlotoxumab for the Management of Clostridioides Difficile Infection (NCT04317963)University of Illinois at Chicago2020-02-12
Oral Vancomycin for Secondary Prophylaxis of Clostridium Difficile Infection (CDI) (NCT04000555)University of South Florida2019-09-01
Bezlotoxumab (BEZLO) In Addition To Standard Of Care (SOC) Vancomycin For The Treatment of Multi-Recurrent Clostridium Difficile Infection (NCT03880539)University of Kansas Medical Center2019-06-25
Phase 2 Study of VE303 for Prevention of Recurrent Clostridioides Difficile Infection (NCT03788434)Vedanta Biosciences, Inc.2019-02-08
Treatment for Clostridium-difficile Infection With IMM529 (NCT03065374)Immuron Ltd.2017-09-01
Outcomes and Data Collection for Fecal Microbiota Transplantation for the Treatment of Recurrent Clostridium Difficile (NCT03562741)Krunal Patel2014-01-16

Track Clostridium Difficile Infection Recurrence automatically

Every clearance here is in the API, with alerts when new ones post.